Not all new (and more expensive) has to be essentially better | Charles Explorer

Not all new (and more expensive) has to be essentially better

Publication at First Faculty of Medicine |

2004

Abstract

Nonsteriodal antiinphlamatory drugs, rofecoxib, cardiovascular risk

Person